JP2010502634A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502634A5
JP2010502634A5 JP2009526819A JP2009526819A JP2010502634A5 JP 2010502634 A5 JP2010502634 A5 JP 2010502634A5 JP 2009526819 A JP2009526819 A JP 2009526819A JP 2009526819 A JP2009526819 A JP 2009526819A JP 2010502634 A5 JP2010502634 A5 JP 2010502634A5
Authority
JP
Japan
Prior art keywords
acid
composition
polymer
group
modifying compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009526819A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502634A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/076700 external-priority patent/WO2008027793A2/en
Publication of JP2010502634A publication Critical patent/JP2010502634A/ja
Publication of JP2010502634A5 publication Critical patent/JP2010502634A5/ja
Pending legal-status Critical Current

Links

JP2009526819A 2006-08-30 2007-08-24 眼科用医薬組成物とその利用法 Pending JP2010502634A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84103606P 2006-08-30 2006-08-30
PCT/US2007/076700 WO2008027793A2 (en) 2006-08-30 2007-08-24 Ophthalmic pharmaceutical compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2010502634A JP2010502634A (ja) 2010-01-28
JP2010502634A5 true JP2010502634A5 (enExample) 2010-10-07

Family

ID=38969502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009526819A Pending JP2010502634A (ja) 2006-08-30 2007-08-24 眼科用医薬組成物とその利用法

Country Status (5)

Country Link
US (1) US20080057022A1 (enExample)
EP (1) EP2068821A2 (enExample)
JP (1) JP2010502634A (enExample)
CN (1) CN101636146A (enExample)
WO (1) WO2008027793A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100087550A1 (en) 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
US9125405B2 (en) * 2008-10-28 2015-09-08 Bausch & Lomb Incorporated Contact lens solution with a tertiary amine oxide
US20110029950A1 (en) * 2009-07-30 2011-02-03 Iftach Ragoler Computer-readable media, methods and computer systems for designing a software application graphically
GB2484843A (en) * 2009-10-15 2012-04-25 Johnson Matthey Plc Polymorphs of Bromfenac sodium
GB201411423D0 (en) * 2014-06-26 2014-08-13 Ge Healthcare As Lipid sterilisation method
AU2021381495A1 (en) 2020-11-23 2023-06-22 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US4192827A (en) * 1974-06-27 1980-03-11 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers
US4136250A (en) * 1977-07-20 1979-01-23 Ciba-Geigy Corporation Polysiloxane hydrogels
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US5278151A (en) * 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
ZA912797B (en) * 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
EP0459148B1 (en) * 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Dry eye treatment composition
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
TW274516B (enExample) * 1993-11-12 1996-04-21 Ciba Geigy Ag
SE9401109D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Opthalmic composition II
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US7001615B1 (en) * 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
CA2839928C (en) * 2003-06-13 2016-10-04 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
TWI358290B (en) * 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
WO2007005421A2 (en) * 2005-07-01 2007-01-11 Bausch & Lomb Incorporated Long lasting alginate dry eye, related methods of manufacture and methods of use
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US20070287752A1 (en) * 2006-06-08 2007-12-13 Burke Susan E Ophthalmic Compositions Comprising A Branched, Glycerol Compound

Similar Documents

Publication Publication Date Title
JP2010502634A5 (enExample)
JP2015025011A5 (enExample)
CN1112918C (zh) 低粘度的眼药组合物
ES2396598T3 (es) Preparaciones en forma de suspensiones acuosas
JP2006528990A5 (enExample)
JP2005523267A5 (enExample)
WO2008011836A3 (es) Soluciones oftálmicas
JP6349057B2 (ja) オロパタジン含有水性組成物
JP6081173B2 (ja) 眼科用水性組成物
WO2005042026A1 (ja) 可逆性熱ゲル化水性組成物
JP2013534527A5 (enExample)
JP2009541387A5 (enExample)
JP2014515383A (ja) PGF2α類似体を含む眼科用製剤
CN100463668C (zh) 可逆性热凝胶化水性药物组合物
JP2005187407A (ja) アレルギー眼疾患用眼科組成物
TWI644663B (zh) 二丁基羥基甲苯的穩定化方法,及含二丁基羥基甲苯之製品(一)
JP6177594B2 (ja) 水性眼科組成物
JP2019532095A5 (enExample)
JP2006312628A (ja) アシタザノラスト含有水性組成物
JP2013519695A5 (enExample)
CN105007919A (zh) 软性隐形眼镜用眼科用组合物
JP2023550393A (ja) セチリジン及びトコフェルソランを含む眼科用組成物
TWI712429B (zh) 水性醫藥組成物
JP5052028B2 (ja) アシタザノラスト含有組成物
CN102085175A (zh) 一种眼用凝胶剂及其制备方法